Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers

Updated on: April 30,2024 0

Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers

Updated on:April 30,2024 0

Investigating the role of fatty acids in cancer cell survival

by Melissa Rohman,Northwestern UniversityIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous ep

Updated on: February 18,2024 17

Investigating the role of fatty acids in cancer cell survival

by Melissa Rohman,Northwestern UniversityIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous ep

Updated on:February 18,2024 17

Genetic test improves clinical care for children with cancer in England

byWellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainWhole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care

Updated on: July 05,2024 0

Genetic test improves clinical care for children with cancer in England

byWellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainWhole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care

Updated on:July 05,2024 0

Treatment beneficial for nonagenarians with lung cancer

(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit for stage I patients, according to a st

Updated on: April 10,2024 18

Treatment beneficial for nonagenarians with lung cancer

(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit for stage I patients, according to a st

Updated on:April 10,2024 18

A maestro that conducts the invasiveness of glioblastoma tumors

by Instituto Gulbenkian de CienciaZEB1 is able to simultaneously switch 'on' and 'of' a large number of genes in cancer cells, in this way functioning as a 'conductor' tha

Updated on: April 10,2024 11

A maestro that conducts the invasiveness of glioblastoma tumors

by Instituto Gulbenkian de CienciaZEB1 is able to simultaneously switch 'on' and 'of' a large number of genes in cancer cells, in this way functioning as a 'conductor' tha

Updated on:April 10,2024 11

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac

Updated on: July 08,2024 0

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac

Updated on:July 08,2024 0

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on: May 23,2024 5

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on:May 23,2024 5

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show

Updated on: May 27,2024 3

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show

Updated on:May 27,2024 3

What do you know about these three rare childhood cancers?

by Laurel KellyCredit: Unsplash/CC0 Public DomainChildhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed

Updated on: January 02,2024 16

What do you know about these three rare childhood cancers?

by Laurel KellyCredit: Unsplash/CC0 Public DomainChildhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed

Updated on:January 02,2024 16

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d

Updated on: March 08,2024 20

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d

Updated on:March 08,2024 20

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on: December 01,2024 0

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on:December 01,2024 0

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on: December 01,2024 0

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on:December 01,2024 0